GSK’s R&D chief to leave for UK gov role?
GlaxoSmithKline’s head of R&D Patrick Vallance is reportedly leaving the firm to take on the role of chief scientific advisor at the government.
Read More
Tag: Emma Walmsley
GSK names new chief executive
GlaxoSmithKline has announced that Emma Walmsley will take over from current chief executive Andrew Witty following his retirement at the end of March next year.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
